Teva Pharmaceutical Industries(TEVA.US)

Last Updated 19:00:00 ET
longbridge loading

Teva Reports Gap In Tardive Dyskinesia Diagnosis Among Patients With Mood Disorders

rttnews·
US
TEVA
+1.06%
US
IHE
+0.50%
US
IXJ
+0.25%
rttnews·
US
TEVA
+1.06%
US
IHE
+0.50%
US
IXJ
+0.25%

Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally?

Simplywall·
US
TEVA
+1.06%
US
IHE
+0.50%
Simplywall·
US
TEVA
+1.06%
US
IHE
+0.50%

Two Setups, One Framework: What eBay and Teva Reveal About Trade Selection

Barchart Option·
US
EBAY
+3.61%
US
TEVA
+1.06%
Barchart Option·
US
EBAY
+3.61%
US
TEVA
+1.06%

17:00 ETBerman Tabacco, Sperling Kenny Nachwalter, LLC and Hilliard Shadowen LLP Announce a Class Action Settlement If You Purchased, Paid For, or Provided Reimbursement for QVAR® and/or QVAR RediHaler® Inhalers From January 1, 2015 through July 31, 2025

prnewswire·
US
TEVA
+1.06%
prnewswire·
US
TEVA
+1.06%

10 Health Care Stocks With Whale Alerts In Today's Session

benzinga_article·
US
TEVA
+1.06%
US
ATAI
+1.64%
US
IBB
+1.46%
benzinga_article·
US
TEVA
+1.06%
US
ATAI
+1.64%
US
IBB
+1.46%

Leader Capital Markets Remains a Buy on Teva (TEVA)

Tip Ranks·
US
TEVA
+1.06%
Tip Ranks·
US
TEVA
+1.06%

UBS Group Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price

Market Beat·
US
TEVA
+1.06%
US
IHE
+0.50%
Market Beat·
US
TEVA
+1.06%
US
IHE
+0.50%

Research Alert: CFRA Lifts Rating On Shares Of Teva Pharmaceutical Industries To Buy From Hold

fidelity·
US
TEVA
+1.06%
fidelity·
US
TEVA
+1.06%
© 2026 Longbridge｜Disclaimer